Skip to Content

Join the 'Genitourinary Surgical and Other Conditions' group to help and get support from people like you.

Genitourinary Surgical and Other Conditions News

Post-Op Opioids: How Much Is Enough?

Posted 27 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 27, 2017 – Amid efforts to stem the U.S. opioid crisis, a new study suggests how long patients should take prescription opioid painkillers after surgery. After general surgery, the ideal duration is four to nine days, said researchers from Brigham and Women's Hospital in Boston. For women's health procedures, four to 13 days is appropriate, while six to 15 days of narcotic painkillers is reasonable for musculoskeletal surgery, according to the study. "An opioid prescription after surgery should balance adequate pain treatment with minimizing the duration of treatment and potential for medication complications, including issues with dependence," wrote Dr. Louis Nguyen and colleagues. Overuse of opioid painkillers – such as OxyContin (oxycodone) and Vicodin (hydrocodone) – has contributed to the opioid abuse epidemic and the skyrocketing rate of overdose deaths in the ... Read more

Related support groups: Suboxone, Oxycodone, Surgery, Tramadol, Hydrocodone, Methadone, Percocet, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Opana, Subutex, Dilaudid, Opana ER, MS Contin, Roxicodone

Many U.S. Women Unaware of Fibroid Treatments: Poll

Posted 29 Aug 2017 by Drugs.com

TUESDAY, Aug. 29, 2017 – Many American women with uterine fibroids don't know there's a minimally invasive embolization technique that may be an alternative to a hysterectomy, a new poll finds. "Misperceptions about uterine fibroids and the treatments available often lead women to undergo invasive and potentially unnecessary surgery for their fibroids, despite more than 20 years of clinical use supporting uterine fibroid embolization," said Dr. James Spies. Spies, a professor of radiology at Georgetown University Medical Center in Washington, D.C., is a former president of the Society of Interventional Radiology (SIR). That group commissioned the online Harris Poll survey of almost 1,200 women. Radiologists perform uterine fibroid embolization (UFE) to treat tumors that grow in the wall of the uterus. These tumors are usually benign, according to the U.S. Office on Women's Health. ... Read more

Related support groups: Hysterectomy, Uterine Leiomyomata / Fibroids, Genitourinary Surgical and Other Conditions

Little Evidence That Vasectomy Raises Prostate Cancer Risk

Posted 18 Jul 2017 by Drugs.com

TUESDAY, July 18, 2017 – For men who have had or might undergo a vasectomy, there is good news: A major study finds scant evidence that the procedure raises their risk of prostate cancer. "At most, there is a trivial association between vasectomy and prostate cancer that is unlikely to be causal," concluded a team led by Dr. R. Jeffrey Karnes, of the Mayo Clinic in Rochester, Minn. The analysis, based on data from 53 studies on the subject, was published online July 17 in the journal JAMA Internal Medicine. As the researchers noted, couples who want to avoid unintended pregnancy often place the responsibility on the female partner. And sometimes, conception occurs despite the use of birth control pills or devices. In contrast, vasectomy has a very low risk of unintended pregnancy. And, "given the lower costs and lower risk of complications for vasectomy compared with [female] tubal ... Read more

Related support groups: Birth Control, Contraception, Prostate Cancer, Genitourinary Surgical and Other Conditions

'Observation' Best Option for Most Low-Risk Prostate Cancer

Posted 13 Jul 2017 by Drugs.com

THURSDAY, July 13, 2017 – Men with early stage prostate cancer who have surgery to remove their tumor do not live longer than those who receive no treatment at all, a long-running clinical trial has concluded. At the same time, nearly one in three men who had the surgery wound up with long-term complications, such as urinary incontinence and erectile dysfunction, said lead researcher Dr. Timothy Wilt. He is a clinical investigator with the Minneapolis Veterans Affairs Health Care System. Based on these findings, cancer experts should revise clinical guidelines so most men with low-risk prostate cancer receive no treatment, Wilt said. Instead, doctors should simply track the progress of their patient's slow-growing cancer by asking about signs and symptoms of disease progression. "Our results demonstrate that for the large majority of men with localized prostate cancer, selecting ... Read more

Related support groups: Surgery, Prostate Cancer, Diagnosis and Investigation, Genitourinary Surgical and Other Conditions

Less Invasive Procedure May Treat Fibroids Without Harming Fertility

Posted 13 Jun 2017 by Drugs.com

TUESDAY, June 13, 2017 – A simple procedure may help women who are suffering from fibroids without jeopardizing their future fertility, a new study suggests. Uterine fibroid embolization (UFE) blocks blood flow to fibroids so they stop growing or shrink. But the technique hasn't been recommended for women who hope to conceive since it was unclear if blood flow might also be blocked to the uterus itself, the researchers explained. According to prior studies, fertility issues strike one of every four women with fibroids, which are benign, muscular tumors on the uterus. The standard treatment for these women is a myomectomy, or surgical removal of the fibroids. However, UFE is an easier, less invasive procedure, the researchers said. "[We chose to do this study] because of the concerns about the effect of UFE on fertility and the likelihood of pregnancy after the procedure," explained ... Read more

Related support groups: Female Infertility, Uterine Leiomyomata / Fibroids, Genitourinary Surgical and Other Conditions

Abused Women Prone to Unnecessary Ovary Removal: Study

Posted 8 Jun 2017 by Drugs.com

THURSDAY, June 8, 2017 – Women who are victims of abuse may be at increased risk for unnecessary ovary removal, a new study suggests. "Our current findings suggest that physical, emotional or sexual abuse predisposes women to seek medical attention for multiple gynecological symptoms, such as abdominal pain or excessive bleeding," said study co-author Dr. Liliana Gazzuola-Rocca. She is a health sciences researcher and psychiatrist at the Mayo Clinic, where the study was done. "These gynecological symptoms may lead the women and their gynecologists to opt for removal of the reproductive organs at a young age – even when these organs are completely normal," she said in a clinic news release. The researchers compared 128 women under age 46 in Minnesota who had had their ovaries removed with women who did not have the procedure. The ovaries were removed for reasons other than cancer or a ... Read more

Related support groups: Female Infertility, Genitourinary Surgical and Other Conditions

Less-Invasive Fibroid Treatment May Be 'Under-Used'

Posted 6 Mar 2017 by Drugs.com

MONDAY, March 6, 2017 – A minimally invasive procedure for uterine fibroids may be "under-used" in U.S. hospitals, compared with surgery, a new study suggests. The study looked at a national sample of hospitals and found that fewer fibroid patients are undergoing hysterectomy – surgical removal of the uterus. But hysterectomy remains much more common compared with a less-invasive procedure called embolization. Fibroids are non-cancerous growths in the wall of the uterus that are usually harmless. But when they cause problems – such as persistent pain and heavy menstrual bleeding – treatment may be necessary. For women with severe symptoms, the go-to has traditionally been hysterectomy, or sometimes surgery to remove the fibroids only. There are other options, though. One is embolization, which involves injecting tiny particles into the small uterine arteries supplying the fibroids. ... Read more

Related support groups: Hysterectomy, Uterine Leiomyomata / Fibroids, Genitourinary Surgical and Other Conditions

Hormonal Drug Boosts Survival After Prostate Cancer's Return: Study

Posted 1 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 1, 2017 – When prostate cancer recurs after surgery, treatment with both radiation and a testosterone-suppressing drug can extend some men's lives, a new clinical trial finds. In a nearly 20-year study, researchers found that the combination therapy cut the risk of death from prostate cancer in half, compared to radiation alone. And that translated into better overall survival, the researchers reported in the Feb. 2 New England Journal of Medicine. After 12 years, just over 76 percent of men who'd received radiation and the hormonal drug bicalutamide (Casodex) were still alive. That compared with just over 71 percent of those who'd received radiation alone. Not all patients benefited from extra treatment, though – including those with "lower-risk" prostate cancer that, despite recurring, appeared less aggressive. And the testosterone-blocking drug carried expected side ... Read more

Related support groups: Prostate Cancer, Transurethral Prostatectomy, Casodex, Bicalutamide, Genitourinary Surgical and Other Conditions, History - Radiation Therapy

Anxiety May Lead to Unneeded Prostate Cancer Treatments

Posted 27 Jan 2017 by Drugs.com

FRIDAY, Jan. 27, 2017 – Anxiety may prompt prostate cancer patients to opt for potentially unnecessary treatments, a new study suggests. The research included more than 1,500 men newly diagnosed with localized prostate cancer. They were more likely to choose surgery and radiation therapy than active surveillance. Active surveillance – also known as "watchful waiting" – is when the patient is monitored closely, but not treated. "Men's level of emotional distress shortly after diagnosis predicted greater likelihood of choosing surgery over active surveillance," said the researchers from the University at Buffalo and Roswell Park Cancer Institute in Buffalo, N.Y. "Importantly, this was true among men with low-risk disease, for whom active surveillance may be a clinically viable option and side effects of surgery might be avoided," they noted. Though the study found an association ... Read more

Related support groups: Anxiety, Anxiety and Stress, Erectile Dysfunction, Urinary Incontinence, Prostate Cancer, Genitourinary Surgical and Other Conditions

U.S. Deaths From Cervical Cancer May Be Underestimated

Posted 23 Jan 2017 by Drugs.com

MONDAY, Jan. 23, 2017 – The number of women who die from cervical cancer in the United States may be higher than previously believed, and the risk is greatest among older and black women, a new study finds. "This is a preventable disease and women should not be getting it, let alone dying from it," study leader Anne Rositch, an assistant professor of epidemiology at Johns Hopkins University in Baltimore, said in a Hopkins news release. Due to big advances in early detection, such as the Pap test, it's long been thought that cervical cancer had made a big retreat in the United States. But the researchers note that prior estimates of cervical cancer death had included women who'd already had a hysterectomy – which can include removal of the uterus and cervix. One in five women in the United States has had a hysterectomy, according to the researchers. Preventive screening such as the Pap ... Read more

Related support groups: Surgery, Cancer, Hysterectomy, Cervical Cancer, Genitourinary Surgical and Other Conditions

Vasectomy May Not Raise Prostate Cancer Risk After All

Posted 19 Sep 2016 by Drugs.com

MONDAY, Sept. 19, 2016 – A large, new study challenges previous research that suggested vasectomies might increase the risk of prostate cancer or dying from it. In the latest finding, researchers found no connection between vasectomies and overall risk of prostate cancer, or of dying from the disease. The American Cancer Society epidemiologists reviewed more than 7,000 prostate cancer deaths, as opposed to the just over 800 prostate cancer deaths that were studied by Harvard scientists in a 2014 study. "Vasectomy is an effective and inexpensive long-term method of birth control," said new study author Eric Jacobs. "This new, large study provides some reassurance that vasectomy is unlikely to meaningfully increase risk of prostate cancer." Jacobs and his colleagues reviewed data on almost 364,000 men aged 40 and older who participated in the Cancer Prevention Study II, a vast research ... Read more

Related support groups: Birth Control, Contraception, Emergency Contraception, Postcoital Contraception, Prostate Cancer, Prostatitis, Prostate Tumor - Benign, Genitourinary Surgical and Other Conditions

Prostate Cancer Treatments: Different Choices for Different Men

Posted 15 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 14, 2016 – A large, decade-long study offers new insights into the treatment dilemmas that many men diagnosed with prostate cancer face: What to do next? The research finds that for certain men, death rates from prostate cancer were roughly the same over several years regardless of whether they chose to be monitored – called "watchful waiting" – or underwent radiation or had their prostate removed. But the findings don't prove that "watchful waiting" is always the best choice. Men who were otherwise largely healthy and chose to be monitored were twice as likely as the others to see their cancer spread over the 10-year study period. "The healthier you are and the longer your life expectancy, the more risk you're taking with surveillance," said Dr. Anthony D'Amico, a professor of radiation oncology at Harvard Medical School. He wrote a commentary accompanying the ... Read more

Related support groups: Surgery, Prostate Cancer, History - Radiation Therapy, Genitourinary Surgical and Other Conditions

Use of Cancer-Linked Fibroid Device Declines After FDA Warning

Posted 23 Aug 2016 by Drugs.com

TUESDAY, Aug. 23, 2016 – The use of power morcellators – cutting tools used in minimally invasive gynecological procedures – has dropped significantly for hysterectomies since the U.S. Food and Drug Administration warned against their use two years ago, a new study finds. Power morcellators have small blades that rotate rapidly. When used in minimally invasive hysterectomies or for the removal of noncancerous growths on the uterus known as fibroids, they slice the tissue into smaller pieces that are removed through a small opening in the abdomen. But tiny pieces of tissue can also spread to other areas of the body. And, sometimes, undetected cancers can be cut up with the healthy tissue. If that cancerous tissue isn't completely removed, those cells can cause cancer elsewhere. That's what prompted the FDA to issue its 2014 warning, the researchers explained. The new study looked only ... Read more

Related support groups: Surgery, Cancer, Hysterectomy, Ovarian Cancer, Uterine Leiomyomata / Fibroids, Genitourinary Surgical and Other Conditions, Urinary Tract Cancer

1 in 5 Ovarian Cancer Patients Doesn't Get Life-Extending Surgery: Study

Posted 4 Jun 2016 by Drugs.com

FRIDAY, June 3, 2016 – Surgery may significantly extend ovarian cancer patients' lives, but one in five women does not have the procedure, a new study finds. "Though surgery isn't right for every patient, we suspect that some women do not receive beneficial surgical treatment because they have poor access to specialty care," said lead researcher Dr. David Shalowitz. He is a fellow in gynecologic oncology at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. "While some women may benefit more from non-surgical treatment, the results of our study showed that on average, women who received surgery lived more than four years, compared to less than one year for those who received only non-surgical treatment," he said in a university news release. The researchers analyzed data from more than 210,000 women diagnosed with ovarian cancer in the United States ... Read more

Related support groups: Surgery, Ovarian Cancer, Surgical Prophylaxis, Genitourinary Surgical and Other Conditions

FDA OKs 'Containment' Bag for Certain Uterine Surgeries

Posted 7 Apr 2016 by Drugs.com

THURSDAY, April 7, 2016 – The U.S. Food and Drug Administration on Thursday said it would permit limited use of a "tissue containment system" in conjunction with laparoscopic power morcellators – devices that grind up tissue in gynecological surgeries. But the FDA still warns against using laparoscopic power morcellators in most women because the procedure can spread undetected cancer cells. The device, called the PneumoLiner, will be permitted only when uterine tissue is not suspected to contain cancer, the agency said. And its maker must warn patients and doctors that the device has not been proven to reduce the risk of spreading cancer during these procedures. "The PneumoLiner is intended to contain morcellated tissue in the very limited patient population for whom power morcellation may be an appropriate therapeutic option – and only if patients have been appropriately informed ... Read more

Related support groups: Surgery, Cancer, Abnormal Uterine Bleeding, Hysterectomy, Uterine Leiomyomata / Fibroids, Genitourinary Surgical and Other Conditions, Urinary Tract Cancer

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Transurethral Prostatectomy, Surgery